Testosterone gels get black-box warnings

FDA is slapping black-box warnings on two testosterone products, AndroGel and Testim, aiming to alert patients to serious side effects among children inadvertently exposed to the gels. Report

Suggested Articles

Teva is reportedly going for a moonshot with a $15 billion drug offer to settle its opioid cases. It's a plan that might just work, one analyst said.

CSL has sued a former exec who its says stole thousands of key documents as he left for competitor Pharming.

Influential U.S. cost watchdog ICER gave its blessing to Johnson & Johnson and Amarin's CV drugs. But there's a big catch for both meds.